Intracerebroventricular Administration of Soy Protein Hydrolysates Reduces Body Weight without Affecting Food Intake in Rats
- 172 Downloads
Some studies suggest that increased consumption of soy protein hydrolysates may cause body weight loss but the mechanism of action is unknown. The objective of this investigation was to determine whether intracerebroventricular (i.c.v.) infusion of soy protein hydrolysates decrease food intake and body weight. Adult male Sprague Dawley rats (n = 24) received i.c.v. injections of soy hydrolysate I (SH I) or soy hydrolysate II (SH II) three times weekly for 2 weeks. Krebs solution and leptin were used as negative and positive controls respectively. SH I (6.5–20 kDa with a strong band at 14 kDa) was produced by hydrolysis with alcalase, and SH II (∼2 kDa) was obtained by hydrolysis and ultrafiltration. Leptin successfully reduced body weight (−1.60 g) 24 h (p = 0.0093) after the third injection. SH I caused significant (p = 0.0009) decreases in body weight (−1.70 g) 24 h after the third injection but not after 48 h. SH II showed a tendency to prevent body weight gain but this effect was short of statistical significance (p < 0.40). Food intake was not affected by any of the soy hydrolysate treatments but leptin injection did cause significant decreases in food intake (p < 0.05). Data suggest that soy alcalase hydrolysate can decrease, in the short term, the rate of body weight gain independently of food consumption. This preliminary data show that soy peptides may play a role on body weight regulation, possibly by increasing energy utilization.
KeywordsLeptin Obesity Soy protein Soy hydrolysate Body weight Food intake
The authors wish to thank the Illinois Soybean Association, USDA Future Foods Initiative and SAI Company for their support of this research. Special thanks are also given to Wenyi Wang, and Maxine Roman for their help in conducting this research.
- 2.Center for Disease Control www.cdc.gov
- 4.Berk Z (1992) Technology of production of edible flours and protein products from soybeans. Technion, Israel Institute of Technology. Haifa, Israel. FAO Agricultural Services Bulletin No. 97. Food and Agriculture Organization of the United Nations RomeGoogle Scholar
- 5.Moriyama T, Kishimoto K, Nagai K, Urade R, Ogawa T, Utsumi S, Maruyama N, Maebuchi M (2004) Soybean β-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of β-oxidation, down regulation of fatty acid synthase, and inhibition of triglyceride absorption. Biosci Biotechnol Biochem 68(2):352–359CrossRefGoogle Scholar
- 7.Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Padyab M, Hu F, Willett W (2007) Soy inclusion in the diet improves features of metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr 85:735–741Google Scholar
- 9.King P (2005) The hypothalamus and obesity. Curr Drug Targets 6:225–240;288:1723–1727Google Scholar
- 10.Janeckova R (2001) The role of leptin in human physiology and pathophysiology. Physiol Res 50:443–459Google Scholar
- 11.Kohno M, Hirotsuka M, Kito M, Matsuzawa Y (2006) Decreases in serum triacylglycerol and visceral fat mediated by dietary soybean β-conglycinin. J Atheroscler Thromb 13:247–255Google Scholar
- 17.Banks W, Farrell C (2003) Impaired transport of leptin across the blood brain barrier in obesity is acquired and reversible. Am J Physiol Endocrinol Metab 285:E10–E15Google Scholar